Katipult Launches DealFlow Central For Institutional Investors
Calgary, Alberta–(Newsfile Corp. – September 11, 2023) – Katipult Technology Corp. (TSXV: FUND) (“Katipult” or…
News
Doubleview Surpasses 7,500m This Season Diamond Drill Coring at the Hat Polymetallic Deposit
Vancouver, BC, Sep 11, 2023 – (ACN Newswire) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
Doubleview Surpasses 7,500m This Season Diamond Drill Coring at the Hat Polymetallic Deposit
Vancouver, British Columbia–(ACN Newswire – September 11, 2023) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
DermTech Appoints Mark Aguillard as Chief Commercial Officer
SAN DIEGO–(BUSINESS WIRE)–DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology…
Viral Nation Sets Itself Apart in the Rapidly Growing Creator Economy with Launch of End-to-End Talent Management and Analytics Platform, Viral Nation_CreatorOS
Proprietary operating system gives Viral Nation customers a competitive advantage through centralized talent discovery, management…
Bird Global Appoints H. Joseph Prodan as CFO
MIAMI–(BUSINESS WIRE)–Bird Global, Inc. (NYSE:BRDS), a leader in environmentally friendly electric transportation, today announced the…
Salesforce Gives $20M to Education, Expanding Pathways into Tech and AI Careers
New grants will benefit high schools and middle schools in cities across the United States…
Scilex Holding Company Generates Record Monthly Revenue In August 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended August 2023, And Year-To-Date As Of August 31 2023, Based On Currently Available Information
PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Scilex Holding Company Generates Record Monthly Revenue In August 2023 And Provides Certain Preliminary Unaudited Financial Results For Gross And Net Sales For The One Month Ended August 2023, And Year-To-Date As Of August 31 2023, Based On Currently Available Information
PALO ALTO, Calif., Sept. 11, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones, M.D., Ph.D. as Chief Medical Officer
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
Palisade Bio Appoints GI Clinical Expert and Biotech Entrepreneur Mitchell Jones, M.D., Ph.D. as Chief Medical Officer
Announces Awarding of Inducement Grant to New Chief Medical Officer Carlsbad, CA, Sept. 11, 2023 (GLOBE…
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 11, 2023 (GLOBE NEWSWIRE) — Centogene N.V….
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib…
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research – MRFF Grant names GTG as sole Industry Partner
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
GENE Positioned at the Forefront of Multi-cancer Clinical Utility Research – MRFF Grant names GTG as sole Industry Partner
Trial to Assess Multi Cancer Genetic Risk Assessment in General Practice MELBOURNE, Australia, Sept. 11,…
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
Revolutionizing Vaccine Discovery: New Data Validates Evaxion AI Platform, Offering Promise to Reduce Risk and Cost in Infectious Disease Vaccine Development
Evaxion is the first organization to validate an AI model that outcompetes state-of-the-art vaccine development…
Biora Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
SAN DIEGO, Sept. 11, 2023 (GLOBE NEWSWIRE) — Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech…